T he ileal pouch-anal anastomosis (IPAA) was first described clinically by Parks and Nicholls in 1978 1 as a surgical technique to maintain fecal continence and avoid a permanent stoma following total proctocolectomy. It has since become the restorative procedure of choice for patients with chronic ulcerative colitis (CUC) given its high patient satisfaction, 2,3 good long-term functional outcome, 4 and acceptable morbidity. [5] [6] [7] [8] [9] [10] [11] We previously reported the 20-year results of 1885 CUC patients who underwent IPAA at Mayo Clinic between 1981 and 2000 to better understand the durability of the pouch. 4 In that study, overall pouch success at 5, 10, 15, and 20 years was 96%, 93%, 92%, and 92%, respectively. The mean daytime and nighttime stool frequency changed significantly between 1 year and 20 years, as did the frequency of daytime and nighttime incontinence, but these numbers were not clinically relevant in changing the quality of life (QoL) of the patients. Interestingly, throughout the follow-up, the proportion of patients using stool bulking agents (50%) remained stable, and the ability of patients to discriminate stool from gas remained constant at 75%. Importantly, over the 20-year study period, QoL remained unchanged, and we concluded that clinical and functional outcomes after IPAA were stable for 20 years following the operation. Because no study has evaluated pouch outcomes for an even longer period, we sought to determine the success of IPAA in terms of functional outcome, QoL, and durability of results fully 30 years after IPAA.
METHODS
Between January 1981 and December 2015, more than 3000 patients with a preoperative diagnosis of CUC underwent an IPAA at Mayo Clinic in Rochester, MN. Among this group of patients, 1895 formed the basis of our previous report in 2007 4 and was in turn used as the patient population for this report as well. Ten patients were excluded due to denial of research authorization. Data from the annually mailed questionnaire was manually entered on receipt into an Excel spreadsheet, and additional data regarding preoperative and postoperative factors were added to the file of each patient. Preoperative data included age, gender, and diagnosis. Postoperative functional data collected included stool frequency, degree of continence, Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.ibdjournal.org).
ability to discriminate stool from gas, use of medication and pads, sexual function, and urinary function. Follow-up was initiated 1 year after restoration of bowel continuity to the pouch (e.g., after ileostomy closure or after IPAA if the operation was performed as a single stage). Standardized questionnaires were mailed out 1 year after IPAA, and then again, every 5 years after IPAA. Survey data were current to January 2016.
QoL data were generated by survey questioning patients regarding how the operation affected the following "activity" or "performance" categories: sport, sexual and social activities, recreation, work around the house, family relationships, and travel. Patients rated these variables on a scale of improved to severely restricted (improved, not affected, mildly restricted, severely restricted) (Supplemental Digital Content 1, http://links.lww.com/IBD/B466).
Fecal incontinence during day and night was recorded as never, occasional (1 or 2 episodes per week), or frequent (more than 2 episodes per week). Pouchitis was primarily diagnosed clinically rather than requiring the preferred endoscopy with Chi-square test for discrete data. Chi-square test with ridit scores used for ordinal data.
biopsy for diagnosis. A patient was considered to have pouchitis if symptoms (watery diarrhea, hematochezia, fatigue, and fever) were present for 2 to 3 days, and such symptoms were alleviated by the administration of ciprofloxacin and/or metronidazole as published previously. 6 Nearly all patients underwent a 2-stage operation as opposed to the increasing number of 3-stage operations being performed currently. 12 For the 2-stage operations, the first stage consisted of a total proctocolectomy with IPAA and diverting ileostomy, and the second stage was an ileostomy closure. For a 3-stage operation, the first stage was a subtotal colectomy with end ileostomy, the second stage was a proctectomy with IPAA formation and diverting loop ileostomy, and the third stage was a loop ileostomy takedown. Pouch construction was performed with the terminal 24 to 30 cm of ileum, creating an ileal reservoir in the 3 most commonly described configurations (1824 Jpouch, 44 S-pouch, and 17 W-pouch). IPAA was completed either by an endorectal mucosectomy of the remaining anal transition zone and a hand-sewn anastomosis of the pouch to the dentate line or, increasingly more common, a double-staple technique in which the pouch is stapled to the top of the anal transition zone. A diverting ileostomy was performed in 96% of patients (30 patients had a one stage operation). The closure of the diverting stoma was accomplished 2 to 3 months after pouch formation (mean [SD], 3.3 [2.9] mo). Nine patients had an emergency operation, whereas all other patients had elective surgery.
Statistical Analysis
Patient subgroups defined by diagnosis, year of IPAA, and age at IPAA were compared using analysis of variance for outcomes with continuous data, and chi-square tests with ridit scores for discrete, ordinal data. Pouch failure was analyzed as the time-to-event outcomes. Pouch survival curves were compared with the log rank test. All statistical tests were 2 sided, and P , 0.05 was considered significant. Statistical analysis was performed using SAS version 9.3 (SAS Institite, Cary, NC) and R version 3.1.1 (R Foundation for Statistical Computing, Vienna, Australia).
RESULTS
A total of 1875 patients were included in the analysis. Of these, 1, 23, 53, 92, 128, 160, and 174 had died by 1, 5, 10, 15, 20, 25 , and 30 years of follow-up, respectively, and corresponding rates to the questionnaires were 80.4%, 72.7%, 70.2%, 58.1%, 49.3%, 39.4%, and 21.6% respectively. One thousand five hundred five, 1345, 1278, 1036, 713, 385, and 102 patients were included in the analysis at 1, 5, 10, 15, 20, 25, and 30 years, respectively.
The mean (SD) age of the 1875 patients at the time of IPAA was 34.1 (10.8) years. There were 1020 men (54%) and 855 women (45%). The mean (SD) number of stools per day before IPAA was 9.5 (6.0). The probability of a functioning pouch at 5 
Functional Outcome Over Time
The median follow-up was 16.1 years (range, 1.0-32.3 yr) after IPAA. Stool frequency during the day increased slightly from a mean (SD) of 5.7 (2.3) at 1 year to 6.2 (2.9) at 30 years (P , 0.001), whereas nighttime frequency increased from 1.5 (1.2) to 2.1 (1.2) (P , 0.001) ( Table 1) . At 1 year, 71% of patients never experienced daytime fecal incontinence. By 10 years, this proportion had decreased to 62% and remained similar at 20, 25, and 30 years (56%, 54%, and 52%, respectively) (Fig. 2 ). This decrease in perfect continence was accompanied by an increase in occasional and a smaller increase in frequent episodes of daytime fecal incontinence. Fecal incontinence at night also worsened over time; 43% of patients never had nocturnal incontinence at 1 year, but this decreased to 29% by 30 years (Fig. 2) . The decrease in perfect nighttime continence was accompanied mainly by an increase in frequent fecal incontinence. The percentage of patients who recorded their stools as liquid or semiliquid increased over the 30-year period from 69% to 85%, whereas the percentage who described their stools as solid decreased from 31% to 15%. Despite these changes, the proportion of patients using medication to alter transit (e.g., stool bulking agents, loperamide, diphenoxylate-atropine, cholestyramine) remained stable at about 50% throughout the follow-up period to 30 years. Importantly, the ability of the patients to discriminate stool from gas remained constant at approximately 75% from year 1 to 25 and did not increase to 80% until 30 years (Table 1) .
Functional Outcomes by 5-Year Period
The functional outcome of the 1875 patients grouped by 5-year period of IPAA surgery is summarized in Table 2 . The mean (SD) age of patients at the time of the operation increased from 31.2 (8.9) years in 1981 to 1991 to 36.3 (12. 2) years in 1996 to 2000. At the time of most recent follow-up, daytime and nighttime stool frequency was comparable as were rates of incontinence that remained stable over increasing periods.
Age and Functional Outcome
At the last follow-up, 278 patients were aged 65 years or more (mean [SD], 70.5 (4.6) yr). Their mean (SD) age at the time of IPAA was 49 (7.3) years. Daytime and nighttime stool frequencies were excellent at 5.7 and 2.4, respectively. Incontinence was described as absent in 47% of patients, occasional in 36% of patients, and frequent in 17% of patients during the day; respective proportions at night were 25%, 43%, and 33%. Stool consistency was solid in 17% of patients and liquid in 6.5%; 71% of patients were able to discriminate gas from stool. However, a higher proportion required stool-regulating medication (53%) ( Table 3) . At the time of IPAA, 137 patients were younger than 20 years. Patients younger than 20 years versus those older than 20 years at the time of IPAA had significantly decreased mean stool frequency at night (P ¼ 0.001) and pad use (P ¼ 0.022) ( Table 4 ).
Sex and Functional Outcome
Among the 1875 patients, 855 were female and 1020 were male. Females were significantly younger (P , 0.001), had decreased mean stool frequency at night (P , 0.001), had increased daytime incontinence (P , 0.001), and increased pad use (P , 0.001) ( Table 5 ).
Diagnosis and Functional Outcome
Among the 1875 patients operated on for CUC, 76 were given the diagnosis of indeterminate colitis (IC) after IPAA, and 46 had their diagnosis changed from CUC to Crohn's disease (CD) after IPAA. Patients with IC had a higher chance of having CD diagnosed at some point in the postoperative course (15%) as compared with those with CUC (2%). The order of diminishing functional outcomes was CUC, IC, and worst in CD. Patients with CD reported an increased frequency in daytime stooling frequency with a mean (SD) of 7.1 (2.8) for CD versus 6.2 (2.7) for CUC versus 7.0 (3.7) for IC (P ¼ 0.008) and daytime bowel incontinence as compared with ulcerative colitis and IC (P , 0.012) ( Table 6 ).
Complications and Pouch Failure
The final postoperative diagnosis was not only associated with functional results but also rates of pouch failure and complications. Pouch success was highest in patients with CUC, with 95% (95% CI, 94%-96%), 95% (93%-96%), 94% (93%-96%), and 94% (91%-96%) of patients having a functioning ileal pouch in place at 5, 10, 20, and 30 years of follow-up, respectively. (Fig. 2) .
The principal complication after IPAA was pouchitis. The 10-year rate of pouchitis was 48% in patients with CUC, 48% in those with IC, and 59% in patients with CD. By 30 years, this rate increased to 80% for CUC, 67% for IC, and 81% for CD. The overall cumulative probability of pouchitis was 81% at 30 years. Stricture, fistulas, and other typical pouch-related complications were most common in patients with CD. The 30-year cumulative probability of a stricture was 56%, 73%, and 75% for CUC, IC, and CD (P ¼ 0.115). The 30-year cumulative probability of a fistula was 14%, 35%, and 68% (P , 0.001). Both complications were also the principal cause of pouch failure. Episodes of small bowel obstruction occurred in 44% of patients at 30 years, with similar probability among the 3 diseases at 30 years (CUC, 44%; IC, 53%; CD, 34%). There was no significant association between inflammatory bowel disease subtype and the risk of small bowel obstruction (P ¼ 0.714). Strictures were usually found early and treated with simple dilation. Because the number of stapled anastomoses in this cohort (started in 1997) was so small, a meaningful observation of the difference in stricture rate between hand-sewn mucosectomy and stapled anastomosis could not be observed (Table 7) .
QoL and Satisfaction
QoL after IPAA with regard to various activities is shown in Figure 3 . Severe restriction was seen in only a handful of patients. Restriction in family relationships was minor and severe in 11% and 1.5% of patients, respectively, at the last available follow-up. Restriction in sexual activities was minor and severe in 19% and 7% of patients, respectively, at the last available followup. Restriction in travel was minor and severe in 34% and 6% of patients, respectively, at the last available follow-up. Restriction in recreation was minor and severe in 31% and 5% of patients, respectively, at the last available follow-up. Ninety-two percent of patients remained in the same employment, and work was not affected by the surgery in 82%. Diet was unchanged in 54% of patients or slightly more restricted in 46% (Fig. 3) .
DISCUSSION
IPAA has become the operation of choice for CUC for its ability to maintain intestinal continuity while removing all diseased and at-risk tissue. Although patients may experience increased frequency of bowel movements, incontinence, or pouchitis, this large cohort of patients with IPAA demonstrated remarkable stability of pouch function over time; 93% of patients had a functioning pouch 30 years after IPAA with very little change in the number of bowel movements, incontinence, or QoL from the first year after the operation.
The overall rate of a functioning pouch at 5, 10, 15, 20, 25, and 30 years was 94.7%, 93.7%, 93.5%, 93.3%, 93.3%, and 93.3%, respectively. Pelvic sepsis has been the predominate cause of pouch failure at our institution, similar to other high volume centers, occurring in about 5% of patients. 13 In a report by Tulchinsky et al, 14 80% of the pouch failure were due to pelvic sepsis; their group reported a cumulative pouch failure rate of 9% at 5 years and 13% at 10 years, suggesting an increase over time. In a multivariate analysis of 494 patients with CUC who had IPAA, Heuschen et al 15 found that long-term corticosteroids significantly increased the risk of pouch-related septic complications at the time of IPAA. In a more recent study, infliximab exposure within 12 weeks of IPAA was associated with early IPAA-specific complications and complications following ileostomy closure. 16 In this study, time from IPAA had little adverse impact on the number of bowel movements during the day (mean, 6.2) or night (mean, 2.1) at 30 years. However, fecal incontinence was more common after 10 years than in the first 5 years after IPAA. Although the number of patients with perfect continence during the day or night declined after 5 years, the rates remained relatively stable from 10 (62% and 34%) to 20 (56% and 29%) to 30 (52% and 29%) years. Other authors have reported a similar decline in perfect continence to approximately 50% at 10 years. 5, 10, 17 The decline in fecal continence is understandable given the decrease in sphincter strength with age, 18 the increase in irritable bowel syndrome with age, 19 and the increase in number of women who experience obstetric sphincter injuries during childbearing. 20 In terms of the number of women who experience sphincter injuries during childbirth, although we did not collect data on which women had undergone childbirth, we did find that all females in the cohort as compared with males had significantly higher rates of daytime incontinence. These findings suggest that the anal sphincter competence will continue to be challenged as patients with IPAA age, and female patients may be at particular risk.
When patients who were older than 55 years at the time of surgery are compared with younger patients (younger than 45 years), several authors reported no significant difference in functional outcome or pouch-related complications. [5] [6] [7] 21, 22 In a recent National Surgical Quality Improvement Plan (NSQIP) study, patients older than 60 years undergoing IPAA had a similar mean number of postoperative complications and only a small, nonsignificant increase in the length of hospital stay. 23 Interestingly, a recent study described that the use of end ileostomy in patients aged 61 to 70 years is decreasing over time because the aforementioned evidence accumulates that IPAA is an acceptable option for older patients with CUC. 24 In the present study, 278 patients were older than 65 years at the last follow-up. Daytime and nighttime frequency and incontinence rates were only slightly higher than the overall cohort, suggesting age alone should not be a contraindication to pouch construction. However, rates of pouch excision with permanent ileostomy have been found to be significantly increased in the cohort over the age of 60 years by Wibmer et al 25 ; on the other hand, these patients were also found to have significantly higher rates of obesity, cardiopulmonary comorbidities, and higher daily corticosteroid use.
Patients with IC had a pouch failure rate comparable with CUC. However, those patients who were later diagnosed with CD had a much higher risk of failure. 26, 27 Because of these findings and consistent results by others, [28] [29] [30] [31] we have not routinely offered IPAA to patients with a preoperative diagnosis of CD. Moreover, we have found that patients who develop CD of the pouch experience high stool frequency, fecal incontinence, pouchitis, and fistulas, which can lead to pouch excision in up to 50% of patients. 30, 32 There is some evidence to suggest that pouch excision has decreased in this era of biologic therapy, as anti-tumor necrosis factor alpha therapeutics have demonstrated efficacy in treating CD of the pouch. [33] [34] [35] Pouchitis is the most common postoperative pouch morbidity with a range in reported incidence of 12% to 70%. 6, 7, [36] [37] [38] Although patients with primary sclerosing cholangitis are more likely to develop pouchitis, no other risk factors have been consistently identified as risk factors for the development of pouchitis. 39 We found an overall 30-year cumulative probability of 80% for the development of pouchitis. Most patients only experienced 1 to 2 episodes, which resolved with antibiotic therapy, and importantly, these episodes did not appear to alter the overall QoL and functional results.
QoL has become an important measure of postoperative outcomes especially given that the objective rates of morbidity and mortality remain exceedingly low. Because there are no generally accepted QoL measurements after IPAA, most studies use a combination of validated general QoL scores and simple wellbeing questions. 5, 11, 17, [40] [41] [42] The majority of patients in this study appeared to enjoy an excellent QoL after IPAA, with good health and good performance scores in all categories, confirming the findings in other studies. 11, 17, [40] [41] [42] Moreover, it has been reported that patients with an IPAA have a better or equivalent QoL than those with a Koch pouch or Brooke ileostomy. 3, 43, 44 Although the methods used to determine the impact on QoL in this study has not been validated, the same questions have been asked in the same manner every 5 years for 30 years, so trends toward improvement or deterioration would be expected if significant changes occurred.
There are several limitations given the nature of this study. The first is that the 30-year outcomes are based on 22% of the patients returning surveys. In addition to including a fraction of the cohort, there is some inherent bias in the reported 30-year results given that surveys are most often returned by patients who have done very well or very poorly. Second, we did not follow each patient longitudinally to conclude which preoperative or intraoperative variables are associated with particular 30-year outcomes. For example, we did not collect the indication for performing a hand-sewn versus stapled anastomosis at the time of surgery. Thus, we did not determine why a given type of anastomosis was performed, or if the functional results were attributed to the type of anastomosis. We rather studied results for the overall cohort at each time point. Third, we did not collect data on how many surveys were collected by each individual patient. It may be that one patient returned surveys at 5 and 30 years, whereas another returned surveys at 10 and 15 years. Again, the data reported represents the cohort in entirety at each time point. Finally, we did not collect information on pouch revision or reconstruction. Thus, we do not have information regarding which patients had a revision or reconstruction, and their subsequent outcomes.
Despite these limitations, we have demonstrated that IPAA for the operative treatment of CUC preserves reliable control of stool function and QoL up to 30 years after the operation. The longterm stability demonstrated by our series underscores our belief that IPAA remains the procedure of choice for eradicating disease, prevention of future malignant disease, and preserving intestinal continuity in patients with CUC, but it remains questionable in patients with CD.
As the operation has evolved to include laparoscopic techniques and double-stapled anastomoses, older and more obese patients are undergoing the operation. Additionally, as an increasing number of biologic therapies are being approved for the treatment of CUC and CD, patients are coming to the operating room immunosuppressed and perhaps sicker. It will therefore be important to determine if these factors change the long-term rate of pouch success in this changing cohort of patients in the future. 
